Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 46

1.

Apolipoprotein E and renal disease.

Liberopoulos E, Siamopoulos K, Elisaf M.

Am J Kidney Dis. 2004 Feb;43(2):223-33. Review.

PMID:
14750087
2.

Etiological significance of apolipoprotein E mutations in lipoprotein glomerulopathy.

Saito T, Ishigaki Y, Oikawa S, Yamamoto TT.

Trends Cardiovasc Med. 2002 Feb;12(2):67-70. Review.

PMID:
11852253
3.

Impact of lipoprotein glomerulopathy on the relationship between lipids and renal diseases.

Saito T, Matsunaga A, Oikawa S.

Am J Kidney Dis. 2006 Feb;47(2):199-211. Review.

PMID:
16431249
4.

ApoE: crossroads between Alzheimer's disease and atherosclerosis.

Stojakovic T, Scharnagl H, März W.

Semin Vasc Med. 2004 Aug;4(3):279-85. Review.

PMID:
15630629
5.

Abnormal lipid metabolism and renal disorders.

Saito T.

Tohoku J Exp Med. 1997 Mar;181(3):321-37. Review.

6.

Signaling pathways of apoE and its role of gene expression in glomerulus diseases.

Zhou TB.

J Recept Signal Transduct Res. 2013 Apr;33(2):73-8. doi: 10.3109/10799893.2013.765466. Epub 2013 Feb 6. Review.

PMID:
23384034
7.

Lipid homeostasis and apolipoprotein E in the development and progression of Alzheimer's disease.

Lane RM, Farlow MR.

J Lipid Res. 2005 May;46(5):949-68. Epub 2005 Feb 16. Review.

8.

A possible structural basis behind the pathogenic role of apolipoprotein E hereditary mutations associated with lipoprotein glomerulopathy.

Stratikos E, Chroni A.

Clin Exp Nephrol. 2014 Apr;18(2):225-9. doi: 10.1007/s10157-013-0886-5. Epub 2013 Oct 23. Review.

PMID:
24149834
9.

Lipoprotein glomerulopathy: a new apolipoprotein E mutation with enhanced glomerular binding.

Sam R, Wu H, Yue L, Mazzone T, Schwartz MM, Arruda JA, Dunea G, Singh AK.

Am J Kidney Dis. 2006 Mar;47(3):539-48. Review.

PMID:
16490634
10.

Apolipoprotein E and familial dysbetalipoproteinemia: clinical, biochemical, and genetic aspects.

Smelt AH, de Beer F.

Semin Vasc Med. 2004 Aug;4(3):249-57. Review.

PMID:
15630634
11.

Apolipoprotein E and diets: a case of gene-nutrient interaction?

Rubin J, Berglund L.

Curr Opin Lipidol. 2002 Feb;13(1):25-32. Review.

PMID:
11790960
12.

Apolipoprotein E structure: insights into function.

Hatters DM, Peters-Libeu CA, Weisgraber KH.

Trends Biochem Sci. 2006 Aug;31(8):445-54. Epub 2006 Jul 3. Review.

PMID:
16820298
13.

Genetic risk factors in myocardial infarction at young age.

Incalcaterra E, Hoffmann E, Averna MR, Caimi G.

Minerva Cardioangiol. 2004 Aug;52(4):287-312. Review.

PMID:
15284679
14.

ApoE gene therapy to treat hyperlipidemia and atherosclerosis.

Harris JD, Evans V, Owen JS.

Curr Opin Mol Ther. 2006 Aug;8(4):275-87. Review.

PMID:
16955690
16.

Lipoprotein glomerulopathy: a new role for apolipoprotein E?

Karet FE, Lifton RP.

J Am Soc Nephrol. 1997 May;8(5):840-2. Review. No abstract available.

17.

Apolipoprotein E polymorphism, age and coronary heart disease.

Kolovou GD, Anagnostopoulou KK.

Ageing Res Rev. 2007 Aug;6(2):94-108. Epub 2006 Dec 20. Review.

PMID:
17224309
18.

Lipoprotein glomerulopathy in China.

Chen Y.

Clin Exp Nephrol. 2014 Apr;18(2):218-9. doi: 10.1007/s10157-013-0873-x. Epub 2013 Oct 29. Review.

PMID:
24165683
19.

Lipoprotein glomerulopathy: first report of 2 not consanguineous Italian men from the same town.

Pasquariello A, Pasquariello G, Innocenti M, Minnei F, Funel N, Lorusso P, Barsotti G.

J Nephrol. 2011 May-Jun;24(3):381-5. doi: 10.5301/JN.2011.7772. Review.

PMID:
21534236
20.

Molecular genetics of renal diseases.

Saito A, Yamazaki H, Nakagawa Y, Arakawa M.

Intern Med. 1997 Feb;36(2):81-6. Review.

Supplemental Content

Support Center